Find your next paid study

Northwestern UniversityNCT06886776

Actual pay is set by the research site.

Phase 4

Houston Emergency Opioid Engagement System (HEROES)

The Houston Emergency Response Opioid Engagement System (HEROES) is a community-based research program integrating assertive outreach, medication-assisted trea…

Opioid Use Disorder

The University of Texas Health Science Center, HoustonNCT03396276

~$25 – $1,000

Actual pay is set by the research site.

A Long-Term Follow-Up Study of Subjects Completing the AU-011-301 (CoMpass) Trial of Bel-sar for Early Choroidal Melanoma (Indeterminate Lesions/Small Choroidal Melanomas)

AU-011-403 is a multicenter long-term follow-up safety and efficacy study of subjects with early CM who previously participated in the AU-011-301 Phase 3 trial…

Choroidal MelanomaIndeterminate Lesions

Aura BiosciencesNCT07338968

~$10 – $1,050

Actual pay is set by the research site.

Phase 1

Mesenchymal Stem Cell Extracellular Vesicles for the Treatment of Recessive Dystrophic Epidermolysis Bullosa Wounds

INVESTIGATIONAL PRODUCT: AGLE-102 is an allogeneic extracellular vesicle (EV) product derived from normal donor mesenchymal stem cells (MSCs). INDICATION AND …

Dystrophic Epidermolysis Bullosa

Aegle TherapeuticsNCT04173650

~$150 – $4,200

Actual pay is set by the research site.

MultimorbidityPhysical Deconditioning

Multicomponent Telerehabilitation to Engage Veterans in Effective Self-Management of ComplexHealth Conditions

Medically complex older Veterans are at greater risk for progressive declines in physical function, lower quality of life, and increasing care needs. Additiona…

VA Office of Research and DevelopmentNCT06288438

~$10 – $675

Actual pay is set by the research site.

Phase 1

Study of NMS-03305293, a Non-Trapping PARP1-Specific PARP Inhibitor in Relapsed Ovarian Cancer

This is a multicenter, open-label Phase Ia/b study on the safety and efficacy of the combination of NMS-03305293 and topotecan in patients with recurrent ovari…

Ovarian Cancer

Nerviano Medical SciencesNCT06930755

~$150 – $4,500

Actual pay is set by the research site.

Bilateral Sensorineural Hearing Loss

Noise Reduction With Hearing Aids

The purpose of this study is to use an optimized version of the SEDA algorithm (SEDA-HA) for hearing aids to evaluate the benefit for listeners with varying de…

NYU Langone HealthNCT07700043

~$10 – $1,125

Actual pay is set by the research site.

Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension

Myotonic Dystrophy type 1 (DM1) is an autosomal dominant multisystemic disorder that causes progressive disability and shortened life expectancy. It is charact…

DM1Myotonic DystrophyMyotonic Dystrophy 1+4 more

Virginia Commonwealth UniversityNCT07700225

Actual pay is set by the research site.

Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma

The aim of the proposed study is to estimate the incidence of Mild Autonomous Cortisol Secretion (MACS) in patients with Adrenal Incidentaloma (AI) and evaluat…

Mild Autonomous Cortisol Secretion (MACS)

The Cleveland ClinicNCT06344143

Actual pay is set by the research site.

Central Line Associated Blood Stream Infections (CLABSI)

Prediction and Reduction of Central Line Associated Blood Stream Infections: A Machine Learning Improvement Study

Prospective, multi-center, cluster-randomized trial of a hospital Infection Preventionist (IP)-led quality improvement study to provide clinical teams with jus…

Swedish Medical CenterNCT07108660

Actual pay is set by the research site.

A Randomized Clinical Trial of Telehealth Treatment for Opioid Use Disorders

This trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.

Opioid Use Disorder

Yale UniversityNCT07362082

Actual pay is set by the research site.

Phase 1

5-AminoLevulinic Acid Aided Resection Margins in Sarcoma (5-ALARMS)

The goal of this study is to learn if the intervention using a fluorescent agent 5-Aminolevulinic acid (5-ALA) to aid in the surgical approach to visualize the…

Soft Tissue Sarcoma (STS)